Company Filing History:
Years Active: 2022
Title: **Andreas Karl Steib: Innovator in Antihelmintic Processes**
Introduction
Andreas Karl Steib is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihelmintic compounds. His innovative approach has led to advancements in the preparation of specific chemical derivatives, showcasing his commitment to improving health outcomes in veterinary medicine.
Latest Patents
Steib holds a patent titled "Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives." This patent revolves around a novel process for synthesizing quinoline compounds of a defined general formula. The innovation outlined in his patent involves the production of intermediate compounds that are crucial for developing effective antihelmintic medications.
Career Highlights
Andreas Karl Steib is currently associated with Bayer Animal Health GmbH, a leading company in animal health solutions. His role reflects a blend of scientific expertise and practical application in the pharmaceutical industry. Steib’s work is integral to the company's mission to enhance the health and well-being of animals through innovative medical treatments.
Collaborations
Throughout his career, Steib has collaborated with esteemed colleagues, including Florian Erver and Frank Memmel. These partnerships have fostered a dynamic environment for research and development, enabling the team to tackle complex challenges in the field of animal health.
Conclusion
Andreas Karl Steib exemplifies the spirit of innovation through his dedication to developing effective veterinary medicines. His patented processes contribute to the advancement of antihelmintic treatments, showcasing the importance of inventors in enhancing health standards in animal care. As he continues to work with Bayer Animal Health GmbH, his influence on the industry remains significant.